OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 175

Showing 26-50 of 175 citing articles:

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
Puthupparampil V. Scaria, Nicole Roth, Kim Schwendt, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10

Pseudouridine and N1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development
Lyana L. Y. Ho, Gabriel H. A. Schiess, Pâmella Miranda, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 5, pp. 418-425
Open Access | Times Cited: 8

Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
Alberto Rubio‐Casillas, David E. Cowley, Mikolaj Raszek, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131427-131427
Closed Access | Times Cited: 8

N1-methyl-pseudouridine is incorporated with higher fidelity than pseudouridine in synthetic RNAs
Tien-Hao Chen, В. А. Потапов, Nan Dai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32

The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
Matthew Halma, Jessica Rose, Theresa A Lawrie
J — Multidisciplinary Scientific Journal (2023) Vol. 6, Iss. 2, pp. 220-235
Open Access | Times Cited: 20

Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 18

Computational design of mRNA vaccines
Yoo-Ah Kim, Kambiz Mousavi, A Khalili Yazdi, et al.
Vaccine (2023) Vol. 42, Iss. 7, pp. 1831-1840
Closed Access | Times Cited: 17

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
Vita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2860-2860
Open Access | Times Cited: 16

The enigmatic epitranscriptome of bacteriophages: putative RNA modifications in viral infections
Nadiia Pozhydaieva, Maik Wolfram-Schauerte, Helene Keuthen, et al.
Current Opinion in Microbiology (2024) Vol. 77, pp. 102417-102417
Open Access | Times Cited: 5

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
Pui Yeng Lam, Natacha Omer, J. Wong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access

Deciphering the Host-Pathogen Interface in COVID-19: The precision molecular insight into epitranscriptomic modifications of high-impact transcripts
Mateusz Maździarz, Katarzyna Krawczyk, Ewa Lepiarczyk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access

Structural and Thermodynamic Consequences of Base Pairs Containing Pseudouridine and N1‐methylpseudouridine in RNA Duplexes
Nivedita Dutta, Indrajit Deb, Joanna Sarzyńska, et al.
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access

Flavin Adenine Dinucleotide (FAD) as a Non-Canonical RNA Cap: Mechanisms, Functions, and Emerging Insights
Pablo Gonzalez-Jabalera, Andres Jäschke
Archives of Biochemistry and Biophysics (2025) Vol. 766, pp. 110326-110326
Closed Access

sa-mRNA influenza vaccine raises a higher and more durable immune response than mRNA vaccine in preclinical models
Cheng Chang, Harsh Patel, Annette Ferrari, et al.
Vaccine (2025) Vol. 51, pp. 126883-126883
Closed Access

Internal cap-initiated translation for efficient protein production from circular mRNA
Keisuke Fukuchi, Yuko Nakashima, Naoko Abe, et al.
Nature Biotechnology (2025)
Closed Access

Developing mRNA Nanomedicines with Advanced Targeting Functions
Ji Wang, Lijun Cai, Ning Li, et al.
Nano-Micro Letters (2025) Vol. 17, Iss. 1
Open Access

BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety
Esraa Alkhalil, Bashar Jarad, Tala Al Saleh, et al.
Prospects in Pharmaceutical Sciences (2025) Vol. 23, Iss. 1, pp. 31-46
Open Access

Promoting Research on Modeling and Simulation
Akihiro Hisaka
YAKUGAKU ZASSHI (2025) Vol. 145, Iss. 3, pp. 223-246
Open Access

Translation—A tug of war during viral infection
Batsheva Rozman, Tal Fisher, Noam Stern‐Ginossar
Molecular Cell (2022) Vol. 83, Iss. 3, pp. 481-495
Open Access | Times Cited: 24

Messenger RNA Therapy for Female Reproductive Health
Rachel VanKeulen-Miller, Owen S. Fenton
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 393-409
Closed Access | Times Cited: 4

Scroll to top